Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Efficacy and Safety of PCSK9 Inhibition With Evolocumab in Reducing Cardiovascular Events in Patients With Metabolic Syndrome Receiving Statin Therapy: Secondary Analysis From the FOURIER Randomized Clinical TrialJAMA Cardiol 2020 Aug 12;[EPub Ahead of Print], P Deedwania, SA Murphy, A Scheen, J Badariene, AL Pineda, N Honarpour, AC Keech, PS Sever, TR Pedersen, MS Sabatine, RP Giugliano
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.